241 related articles for article (PubMed ID: 23733874)
41. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
[TBL] [Abstract][Full Text] [Related]
42. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
[TBL] [Abstract][Full Text] [Related]
43. [Anti-tumor immunity in adult T-cell leukemia].
Kannagi M
Uirusu; 2004 Jun; 54(1):67-74. PubMed ID: 15449906
[TBL] [Abstract][Full Text] [Related]
44. T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.
Rowan AG; Witkover A; Melamed A; Tanaka Y; Cook LB; Fields P; Taylor GP; Bangham CR
PLoS Pathog; 2016 Nov; 12(11):e1006030. PubMed ID: 27893842
[TBL] [Abstract][Full Text] [Related]
45. Tumor immunity against adult T-cell leukemia.
Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
[TBL] [Abstract][Full Text] [Related]
46. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
Tanaka Y; Isobe A; Masuda M; Tozawa H; Koyanagi Y; Yamamoto N; Shida H
J Immunol; 1991 Nov; 147(10):3646-52. PubMed ID: 1940363
[TBL] [Abstract][Full Text] [Related]
47. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
48. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
[TBL] [Abstract][Full Text] [Related]
49. Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.
Maeda N; Ohashi T; Chagan-Yasutan H; Hattori T; Takahashi Y; Harigae H; Hasegawa H; Yamada Y; Fujii M; Maenaka K; Uede T
Retrovirology; 2015 Nov; 12():99. PubMed ID: 26597716
[TBL] [Abstract][Full Text] [Related]
50. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H
J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528
[TBL] [Abstract][Full Text] [Related]
51. [HTLV-1-targeted immunotherapy].
Suehiro Y
Rinsho Ketsueki; 2016; 57(10):2250-2258. PubMed ID: 27795537
[TBL] [Abstract][Full Text] [Related]
52. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
[TBL] [Abstract][Full Text] [Related]
53. Tax unleashed: fulminant Tax-positive Adult T-cell Leukemia/Lymphoma after failed allogeneic stem cell transplantation.
Ghez D; Renand A; Lepelletier Y; Sibon D; Suarez F; Rubio MT; Delarue R; Buzyn A; Beljord K; Tanaka Y; Varet B; Hermine O
J Clin Virol; 2009 Dec; 46(4):378-80. PubMed ID: 19836302
[TBL] [Abstract][Full Text] [Related]
54. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
[TBL] [Abstract][Full Text] [Related]
55. [Therapeutic effect of agonistic CD40 monoclonal antibody combined with CTL on hu-SCID mouse B lymphoma model].
Zhou H; Xi H; Ma QR; Chen C; Zhang F; Zhang XG; Gu ZJ
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):181-5. PubMed ID: 17649632
[TBL] [Abstract][Full Text] [Related]
56. NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma.
Horie R
Int Rev Immunol; 2007; 26(5-6):269-81. PubMed ID: 18027201
[TBL] [Abstract][Full Text] [Related]
57. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
[TBL] [Abstract][Full Text] [Related]
58. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.
Boyle TJ; Berend KR; DiMaio JM; Coles RE; Via DF; Lyerly HK
Surgery; 1993 Aug; 114(2):218-25; discussion 226. PubMed ID: 8393595
[TBL] [Abstract][Full Text] [Related]
59. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
Ohashi T; Hanabuchi S; Suzuki R; Kato H; Masuda T; Kannagi M
J Virol; 2002 Jul; 76(14):7010-9. PubMed ID: 12072501
[TBL] [Abstract][Full Text] [Related]
60. Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression.
Furuta RA; Sugiura K; Kawakita S; Inada T; Ikehara S; Matsuda T; Fujisawa J
J Virol; 2002 Mar; 76(6):2703-13. PubMed ID: 11861837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]